Table 4.
Differences in inflammatory marker changes among three different levels of AP
| WBC | Neutrophils | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Coefficient | 95% CI | p Value* | Coefficient | 95% CI | p Value* | ||||
| M | 1.77 | -7.75 | 11.40 | 0.721 | -3.51 | -18.44 | 11.74 | 0.653 | |
| H | 27.0 | 17.48 | 36.63 | 0.000 | 26.76 | 12.06 | 41.90 | 0.000 | |
| Lymphocytes | Monocytes | ||||||||
| Coefficient | 95% CI | p Value* | Coefficient | 95% CI | p Value* | ||||
| M | 3.35 | -9.03 | 15.34 | 0.594 | 2.11 | -6.90 | 10.97 | 0.647 | |
| H | 32.22 | 19.85 | 44.22 | 0.000 | 28.23 | 19.28 | 36.95 | 0.000 | |
| Eosinophils | Basophils | ||||||||
| Coefficient | 95% CI | p Value* | Coefficient | 95% CI | p Value* | ||||
| M | 25.64 | 3.93 | 46.41 | 0.022 | 14.33 | -4.89 | 32.78 | 0.142 | |
| H | 48.93 | 27.25 | 70.12 | 0.000 | 11.5 | -8.00 | 29.79 | 0.236 | |
| IL-1β | IL-10 | ||||||||
| Coefficient | 95% CI | p Value* | Coefficient | 95% CI | p Value* | ||||
| M | 0.39 | -0.09 | 0.86 | 0.116 | 0.05 | -0.09 | 0.19 | 0.503 | |
| H | 0.76 | 0.29 | 1.23 | 0.003 | 0.17 | 0.03 | 0.32 | 0.020 | |
| IL-6 | TNF-α | ||||||||
| Coefficient | 95% CI | p Value* | Coefficient | 95% CI | p Value* | ||||
| M | 0.05 | -0.02 | 0.11 | 0.174 | -0.00 | -0.08 | 0.07 | 0.920 | |
| H | 0.10 | 0.04 | 0.17 | 0.004 | 0.97 | 0.02 | 0.17 | 0.011 | |
| CRP | |||||||||
| Coefficient | 95% CI | p Value* | |||||||
| M | 0.05 | -0.06 | 0.16 | 0.370 | |||||
| H | 0.17 | 0.06 | 0.28 | 0.003 | |||||
Mixed effect models adjusted for gender, age, and BMI. Exposure scenario with reference to ‘Low level AP and PE exposure’. *: Statistical significance in the results of the linear mixed-effects model. M: Medium level AP and PE exposure; H: High level AP and PE exposure. Abbreviations WBC. White Blood Cell; IL, interleukin; TNF-α, tumour necrosis factor α; CRP, C reactive protein